Approval · Notice of Compliance 20562 · 2018
ONSIOR: Notice of Compliance 20562
Issued March 6, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20562
- Date
- March 6, 2018
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONSIOR | 02374382 | Marketed |
Medicinal ingredients
- ROBENACOXIB 20 MG per ML